Tumour regression and improved gastrointestinal tolerability from controlled release of SN-38 from novel polyoxazoline-modified dendrimers. (2017)
Attributed to:
Bar-Coded Biomaterials - Designing Self-Authenticating Medicines
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jconrel.2016.12.034
PubMed Identifier: 28043863
Publication URI: http://europepmc.org/abstract/MED/28043863
Type: Journal Article/Review
Volume: 247
Parent Publication: Journal of controlled release : official journal of the Controlled Release Society
ISSN: 0168-3659